Table 2.

Spearman’s rank-order correlations for dolutegravir AUC_0-24 estimates and change in modified mini screen score and sleep quality form baseline to weeks 4, 12, and 24

	Spearman’s rank-order correlation for dolutegravir AUC0-24 and change in MMS from baseline				Spearman’s rank-order correlation for dolutegravir AUC0-24 and change in sleep quality from baseline
Timepoint	n	rs	95% CI	P value	n	rs	95% CI	P value
Week 4	461	−0.062	−0.153 to +0.029	0.186	419	−0.036	−0.127 to 0.056	0.468
Week 12	461	−0.099	−0.188 to −0.011	0.033	411	−0.101	−0.201 to −0.001	0.041
Week 24	461	−0.129	−0.222 to −0.036	0.006	418	0.002	−0.098 to 0.101	0.968

AUC_0-24, area under the concentration-time curve; MMS, modified mini score; r_s, Spearman’s rank-order correlation.